These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9776581)

  • 41. Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia.
    Wassom DL; Loegering DA; Solley GO; Moore SB; Schooley RT; Fauci AS; Gleich GJ
    J Clin Invest; 1981 Mar; 67(3):651-61. PubMed ID: 7204553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
    Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
    Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two-laser dual-immunofluorescence confocal laser scanning microscopy using Cy2- and Cy5-conjugated secondary antibodies: unequivocal detection of co-localization of neuronal markers.
    Wouterlood FG; Van Denderen JC; Blijleven N; Van Minnen J; Härtig W
    Brain Res Brain Res Protoc; 1998 Jan; 2(2):149-59. PubMed ID: 9473644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist.
    Simon HU; Weber M; Becker E; Zilberman Y; Blaser K; Levi-Schaffer F
    J Immunol; 2000 Oct; 165(7):4069-75. PubMed ID: 11034418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole-blood flow-cytometric analysis of eosinophil EG2 expression as a marker of the pathological conditions of asthma.
    Kuwasaki T; Chihara J; Kayaba H; Kamata Y; Oyamada H; Saito N; Shioya T; Sasaki M; Kagaya M; Tsuda A
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():77-80. PubMed ID: 9758904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Granulocyte storage and antigen stability.
    Chun H; Cipolone K; Procter J; Stroncek DF
    Transfusion; 1999 Sep; 39(9):983-90. PubMed ID: 10533825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils.
    Tai PC; Spry CJ
    Clin Exp Immunol; 1990 Jun; 80(3):426-34. PubMed ID: 2197048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-8 and the activation of eosinophils and neutrophils following nasal allergen challenge.
    Jacobi HH; Poulsen LK; Reimert CM; Skov PS; Ulfgren AK; Jones I; Elfman LB; Malling HJ; Mygind N
    Int Arch Allergy Immunol; 1998 May; 116(1):53-9. PubMed ID: 9623510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Eosinophil activation in acute asthma attacks evaluated by electronmicroscopic findings of eosinophils and the concentration of eosinophil cationic protein in sputum].
    Oohashi Y; Motojima S; Kushima A; Tateishi K; Fukuda T; Makino S
    Arerugi; 1991 Oct; 40(10):1265-71. PubMed ID: 1772349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Partial purification and biological properties of an eosinophil-activating factor.
    Thorne KJ; Richardson BA; Veith MC; Tai PC; Spry CJ; Butterworth AE
    Eur J Immunol; 1985 Nov; 15(11):1083-91. PubMed ID: 2998804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma.
    Carlson M; Håkansson L; Peterson C; Stålenheim G; Venge P
    J Allergy Clin Immunol; 1991 Jan; 87(1 Pt 1):27-33. PubMed ID: 1846890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of prednisolone on eosinophils, IL-5, eosinophil cationic protein, EG2+ eosinophils, and nitric oxide metabolites in the sputum of patients with exacerbated asthma.
    Jang AS; Choi IS; Koh YI; Jeong TK; Lee KY; Kim YS; Lee JU; Park CS
    J Korean Med Sci; 2000 Oct; 15(5):521-8. PubMed ID: 11068988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein.
    Colombel JF; Torpier G; Janin A; Klein O; Cortot A; Capron M
    Gut; 1992 Sep; 33(9):1190-4. PubMed ID: 1427370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of RANTES on intracellular expression of EG2 antigen in eosinophils.
    Kakazu T; Chihara J; Saito A; Higashimoto I; Yamamoto T; Kurachi D; Nakajima S
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():43-4. PubMed ID: 7549521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulation of neutrophil interleukin-8 production by eosinophil granule major basic protein.
    Page SM; Gleich GJ; Roebuck KA; Thomas LL
    Am J Respir Cell Mol Biol; 1999 Aug; 21(2):230-7. PubMed ID: 10423406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EliCell: a gel-phase dual antibody capture and detection assay to measure cytokine release from eosinophils.
    Bandeira-Melo C; Gillard G; Ghiran I; Weller PF
    J Immunol Methods; 2000 Oct; 244(1-2):105-15. PubMed ID: 11033023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Localization of eosinophil granule major basic protein in paracoccidioidomycosis lesions.
    Wagner JM; Franco M; Kephart GM; Gleich GJ
    Am J Trop Med Hyg; 1998 Jul; 59(1):66-72. PubMed ID: 9684630
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluorescein isothiocyanate labelled bovine serum albumin (FITC-BSA) as a model protein drug: opportunities and drawbacks.
    Wischke C; Borchert HH
    Pharmazie; 2006 Sep; 61(9):770-4. PubMed ID: 17020153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma.
    Frigas E; Loegering DA; Solley GO; Farrow GM; Gleich GJ
    Mayo Clin Proc; 1981 Jun; 56(6):345-53. PubMed ID: 7230899
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of extracellular matrix proteins on platelet-activating factor-induced eosinophil chemotaxis.
    Yoshikawa M; Matsumoto K; Iida M; Akasawa A; Moriyama H; Saito H
    Int Arch Allergy Immunol; 2002; 128 Suppl 1():3-11. PubMed ID: 12065903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.